Identification of a Novel Tumor Inflammation Signature for Risk Stratification, Prognosis Prediction, and Immune Status in Colorectal Cancer

<div>(a) Prognostic nomogram for predicting overall survival rate of CRC patients. (b) The 1-year, 3-year, and 5-year calibration curves of the nomogram model.</div>

BioMed Research International

fig4

Figure 4

Figure 4: Identification of a Novel Tumor Inflammation Signature for Risk Stratification, Prognosis Prediction, and Immune Status in Colorectal Cancer 

Figure 4 | Identification of a Novel Tumor Inflammation Signature for Risk Stratification, Prognosis Prediction, and Immune Status in Colorectal Cancer 